Skip to main content
European Commission logo print header

Human toll-like receptor family in chronic and degenerative diseases

Objetivo

There is a pressing need for more effective treatments for chronic degenerative diseases such as rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) This proposal aims to resolve the molecular mechanisms which underlie these diseases by focusing on the highly novel family of toll-like receptors TLRs) whose members have been linked with onset and progression of inflammatory diseases The proposal plans to explore all aspects of TLR biology, from regulation of their expression, to mechanism of action, to role in inflammatory diseases Several key technologies will be used, including the generation of knockout mice, animal model of disease, analysis of clinical samples, genomics and is predicted that such a multidisciplinary approach will define the role of TLRS in RA and IBD and will suggest new therapies fore these debilitaing diseases

Convocatoria de propuestas

Data not available

Régimen de financiación

CSC - Cost-sharing contracts

Coordinador

NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Aportación de la UE
Sin datos
Dirección
Belfield
4 DUBLIN
Irlanda

Ver en el mapa

Coste total
Sin datos

Participantes (5)